Post-Surgical Pain
A 2024 review found only 2 of 11 trials showed a benefit — evidence is thin, and standard surgical analgesia remains primary.
Pain Emerging
What the research says
With the opioid crisis, 'does cannabis cut post-surgical pain and painkiller use?' became a hot research question — and the early answer is largely no. A 2024 review of 11 clinical trials of cannabinoids for acute postoperative pain found meaningful benefit in only 2. The trials used different products, routes, and timing (before, during, or after surgery), and none showed a consistent reduction in opioid use.
Acute surgical pain is a different physiology than chronic pain — inflammation, tissue injury, and short timelines — and treatments that work for chronic pain do not automatically transfer. Small sample sizes and heterogeneous products also weaken whatever positive signals appeared.
The honest caveats
The recovery ward is the worst place to experiment: cannabis can interact with anesthetics and opioids (additive sedation, respiratory depression risk), and anesthesia-related nausea can be made worse. Standard postoperative care — scheduled acetaminophen, NSAIDs, regional blocks, and short-course opioids where needed — is far better studied. If you use cannabis regularly, the safest move is telling your surgical team beforehand, because tolerance and interactions genuinely change their medication choices.
Compounds to explore
These are the compounds — terpenes and cannabinoids — that the research connects to this condition. They are starting points for reading a COA or choosing a product, not prescriptions. Each has its own guide with more detail.
Cannabinoid THC The most-studied compound in surgical pain trials — results were mostly negative. Cannabinoid CBD Used as an adjunct in some trials; no consistent benefit. Terpene beta-caryophyllene Anti-inflammatory terpene; theoretical interest only.